Small lipidated anti-obesity compounds derived from neuromedin U.

about

Lipopeptides as therapeutics: applications and in vivo quantitative analysis.Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice.Peptides: Production, bioactivity, functionality, and applications.

P2860

Q39037677-EEB68DF2-E3EC-44F8-8911-71BCE38A1023 Q47197295-BA3169F7-4460-411B-B28E-44CC31FEE36B Q47666763-91D0266F-2B44-4739-B3EB-89BADDFD547F

P2860

Small lipidated anti-obesity compounds derived from neuromedin U.

Item

http://www.wikidata.org/entity/Q35708420

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Small lipidated anti-obesity compounds derived from neuromedin U.

@ast

Small lipidated anti-obesity compounds derived from neuromedin U.

@en

type

Item

label

Small lipidated anti-obesity compounds derived from neuromedin U.

@ast

Small lipidated anti-obesity compounds derived from neuromedin U.

@en

prefLabel

Small lipidated anti-obesity compounds derived from neuromedin U.

@ast

Small lipidated anti-obesity compounds derived from neuromedin U.

@en

P1476

Small lipidated anti-obesity compounds derived from neuromedin U.

@en

P2093

Alan J Waring

http://www.w3.org/2001/XMLSchema#string

Ewa D Micewicz

http://www.w3.org/2001/XMLSchema#string

Gary B Willars

http://www.w3.org/2001/XMLSchema#string

Mohamad Navab

http://www.w3.org/2001/XMLSchema#string

Omar S O Bahattab

http://www.w3.org/2001/XMLSchema#string

Piotr Ruchala

http://www.w3.org/2001/XMLSchema#string

William H McBride

http://www.w3.org/2001/XMLSchema#string

P2860

Obesity: Genetic, molecular, and environmental aspects

Neuromedin U is a potent agonist at the orphan G protein-coupled receptor FM3

Identification and functional characterization of a novel subtype of neuromedin U receptor

Identification of receptors for neuromedin U and its role in feeding

Identification and characterization of two neuromedin U receptors differentially expressed in peripheral tissues and the central nervous system

Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression

The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2)

Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S

Lipid rafts and signal transduction

The emerging role of lysophosphatidic acid in cancer

P304

616-626

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EJMECH.2015.07.020

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Julian P Whitelegge

P577

2015-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280077880

http://www.w3.org/2001/XMLSchema#string

P698

26204509

http://www.w3.org/2001/XMLSchema#string

P932

4543588

http://www.w3.org/2001/XMLSchema#string

Small lipidated anti-obesity compounds derived from neuromedin U.

about

P2860

P2860

Small lipidated anti-obesity compounds derived from neuromedin U.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932